For the second time, UiO:Life Science hosts a conference about research, education, innovation, business and politics in life science, and this year with a special focus on health.
This will be the 2nd conference hosted by UiO:Life Science for all of you who are interested in research, education, innovation, business and politics in life sciences.
For the 2017 conference the university is collaborating with Oslo University Hospital and the Association of the Pharmaceutical Industry in Norway – LMI. It has been decided that a pre-event at the 15th of February will be a part of the conference so you should save all three dates.
This year, the University of Oslo (UiO) is collaborating with Oslo University Hospital and the Association of the Pharmaceutical Industry in Norway (LMI). The first day of the event, has the title Partnership4Life, and is intended for businesses wanting to partner up with academia and vice versa. Erling Nordbo, CEO of Norway’s new health incubator Aleap will be speaking as well as Jan-Olof Jacke, CEO of AstraZeneca, Oliver Rittgen, CEO of Bayer Nordic and Tine Hartmann Nielsen from Invest in Denmark. There will also be a plenary discussion on the topic “Life Science as an industry in Norway – Can we succeed without a strong homebased industry?” and sessions on partnership for growth and better health, ending with a plenary discussion on “How can we turn public health data and research into business?”
The second day, and the start of the main conference includes perspectives from academia, businesses and politics. Speakers include Anna O’Garra, Associate research Director at the Francis Crick Institute, Kjetil Taskén, Director at the Centre for Molecular Medicine in Norway, Karita Bekkemellen, CEO of the Association of the Pharmaceutical Industry in Norway (LMI) and Laura Chirica, CEO of Immunovia. The last day of the event will highlight the planned life science building at UiO in Gaustadbekkdalen, planned to be completed in 2023. Some of the challenges and will ask challenges with the project and researchers from UiO and external collaborators will give short introductions followed by a debate and questions.